
LIVE: WHO Meeting on 2026-27 Northern Hemisphere Influenza Vaccine Composition
The World Health Organization convened an information meeting to finalize the composition of the 2026‑27 Northern Hemisphere influenza vaccine. Senior officials, including Dr. Chikui Hikawazu and Dr. Maria Van Kokov, highlighted the critical role of the Global Influenza Surveillance and Response System (GISAID) in providing the data that underpins bi‑annual strain updates. Analysis of the latest surveillance reports showed a clear shift in circulating subtypes: H3N2 viruses now dominate, while H1N1 PDM09 viruses have migrated to D3.1‑related clades across most regions. Notably, influenza B viruses were absent from the dataset, and the southern hemisphere continued low‑level activity beyond its typical season. Genetic and antigenic characterizations confirmed these trends, revealing regional heterogeneity that will influence strain selection. Dr. Hikawazu emphasized that updating vaccine composition is a scientific necessity, not a tradition, and praised the 75‑year‑old GISAID network for its reliability. Dr. Van Kokov echoed this sentiment, calling the surveillance system an “irreplaceable asset” that translates data into life‑saving decisions. The meeting also recognized the collaborative effort of national centers, academic partners, and manufacturers in turning raw virus samples into actionable vaccine recommendations. The implications are immediate: manufacturers must incorporate the newly dominant H3N2 and D3.1‑type H1N1 strains into their production pipelines, accounting for regional variations to maximize efficacy. Successful implementation will protect millions from severe influenza, reduce healthcare burdens, and sustain the global preparedness framework for future respiratory threats.

How the Health Technology Access Programme (HTAP) Operates?
The World Health Organization’s Health Technology Access Programme (HTAP) is designed to close the gap between high‑income manufacturers and low‑ and middle‑income countries that struggle with limited production capacity, skilled workforces, and costly health products. By convening technology owners, local...

Supporting Rehabilitation Needs
After two years of conflict, over 42,000 Gaza residents suffer severe injuries, including more than 5,000 amputations. Rehabilitation facilities are largely destroyed and many specialists have been killed or displaced, leaving a critical service gap. WHO and NORWAC are working...

LIVE | Dr Tedros at the World Forum
Dr Tedros addressed the World Forum, reminding listeners that the recent Munich Security Conference highlighted a paradox: while nations ramp up defense spending, they overlook an "invisible enemy"—global pandemics. He quantified COVID‑19’s devastation, noting roughly 20 million deaths and a $10 trillion...

Your Daily Dose: More than 80% of Children Can Survive when Cancer Is Found Early and Treated.
International Childhood Cancer Day highlights that early detection and treatment can enable more than 80% of children with cancer to survive. The video, narrated by a physician‑mother, underscores that while childhood cancer remains rare, the most common forms—leukemia, brain tumors,...